Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, Jacobs MB, Hasenkampf NR, Martin DS, Narasimhan S, Phillippi-Falkenstein KM, Purcell JE, Ratterree MS, Philipp MT.

PLoS One. 2012;7(1):e29914. doi: 10.1371/journal.pone.0029914. Epub 2012 Jan 11. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/f84663e3-0a2c-4243-8f97-3a58133c1b0f. PLoS One. 2012;7(4):10.1371/annotation/4cafed66-fb84-4589-a001-131d9c50aea6.

2.

Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.

Hodzic E, Imai D, Feng S, Barthold SW.

PLoS One. 2014 Jan 23;9(1):e86907. doi: 10.1371/journal.pone.0086907. eCollection 2014.

3.

Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.

Bockenstedt LK, Mao J, Hodzic E, Barthold SW, Fish D.

J Infect Dis. 2002 Nov 15;186(10):1430-7. Epub 2002 Oct 23.

4.

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ.

Antimicrob Agents Chemother. 2010 Feb;54(2):643-51. doi: 10.1128/AAC.00788-09. Epub 2009 Dec 7.

5.

Persistence of Borrelia burgdorferi following antibiotic treatment in mice.

Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW.

Antimicrob Agents Chemother. 2008 May;52(5):1728-36. doi: 10.1128/AAC.01050-07. Epub 2008 Mar 3.

6.

Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA.

J Clin Invest. 2012 Jul;122(7):2652-60. doi: 10.1172/JCI58813. Epub 2012 Jun 25.

7.

Dynamic longitudinal antibody responses during Borrelia burgdorferi infection and antibiotic treatment of rhesus macaques.

Embers ME, Hasenkampf NR, Jacobs MB, Philipp MT.

Clin Vaccine Immunol. 2012 Aug;19(8):1218-26. doi: 10.1128/CVI.00228-12. Epub 2012 Jun 20.

8.

Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.

Salo J, Jaatinen A, Söderström M, Viljanen MK, Hytönen J.

PLoS One. 2015 Mar 27;10(3):e0121512. doi: 10.1371/journal.pone.0121512. eCollection 2015.

9.

Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice, after antibiotic treatment.

Liegner KB.

J Infect Dis. 2003 May 15;187(10):1676; author reply 1676. No abstract available.

10.

Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design.

Wormser GP, Baker PJ, O'Connell S, Pachner AR, Schwartz I, Shapiro ED.

Vector Borne Zoonotic Dis. 2012 Jul;12(7):535-8. doi: 10.1089/vbz.2012.1012. Epub 2012 May 23. Review.

11.

Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.

Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K.

Antimicrob Agents Chemother. 2015 Aug;59(8):4616-24. doi: 10.1128/AAC.00864-15. Epub 2015 May 26.

12.

Antibiotic treatment of animals infected with Borrelia burgdorferi.

Wormser GP, Schwartz I.

Clin Microbiol Rev. 2009 Jul;22(3):387-95. doi: 10.1128/CMR.00004-09. Review.

13.

Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.

Strle K, Jones KL, Drouin EE, Li X, Steere AC.

Am J Pathol. 2011 Jun;178(6):2726-39. doi: 10.1016/j.ajpath.2011.02.018.

14.

Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability.

Iyer R, Mukherjee P, Wang K, Simons J, Wormser GP, Schwartz I.

J Clin Microbiol. 2013 Mar;51(3):857-62. doi: 10.1128/JCM.02785-12. Epub 2012 Dec 26.

15.

Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.

Pavia CS, Wormser GP.

Antimicrob Agents Chemother. 2014 Nov;58(11):6701-3. doi: 10.1128/AAC.03751-14. Epub 2014 Aug 25.

16.

Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.

Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC.

Arthritis Rheum. 2007 Dec;56(12):4216-25.

17.

Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.

Yrjänäinen H, Hytönen J, Hartiala P, Oksi J, Viljanen MK.

APMIS. 2010 Sep 1;118(9):665-73. doi: 10.1111/j.1600-0463.2010.02615.x.

PMID:
20718718
18.

Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.

Feng J, Auwaerter PG, Zhang Y.

PLoS One. 2015 Mar 25;10(3):e0117207. doi: 10.1371/journal.pone.0117207. eCollection 2015.

19.

Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment.

Malawista SE, Barthold SW, Persing DH.

J Infect Dis. 1994 Nov;170(5):1312-6.

PMID:
7963735
20.

Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease.

Cadavid D, O'Neill T, Schaefer H, Pachner AR.

Lab Invest. 2000 Jul;80(7):1043-54.

PMID:
10908149
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk